SCHEMBL5022859

SCHEMBL5022859

COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CCNC1(C(N)=O)CN(C(C)C)C1

nearest known ligand 0.74

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
EGFR P00533 20/20 0.74

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5023579 0.92 EGFR (0.73) EGFR
SCHEMBL5023520 0.88 EGFR (0.65) EGFR
Hydrochloric Acid SCHEMBL5023596 0.88 EGFR (0.65) EGFR
SCHEMBL4453385 0.85 EGFR (1.00) EGFR
SCHEMBL5400957 0.84 EGFR (0.60) EGFR
SCHEMBL5025370 0.83 EGFR (0.60) EGFR
SCHEMBL4455327 0.81 EGFR (1.00) EGFR
SCHEMBL4446933 0.80 EGFR (0.86) EGFR
Hydrochloric Acid SCHEMBL5025496 0.79 EGFR (0.65) EGFR
SCHEMBL4444652 0.79 EGFR (1.00) EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1713781-B1 QUINAZOLINE DERIVATIVES ASTRAZENECA AB (SE) 2008-11-05 EP claimed
EP-1713781-B1 QUINAZOLINE DERIVATIVES ASTRAZENECA AB (SE) 2008-11-05 EP disclosed
EP-1713781-A1 QUINAZOLINE DERIVATIVES AstraZeneca AB (SE) 2006-10-25 EP disclosed
WO-2005075439-A1 QUINAZOLINE DERIVATIVES ASTRAZENECA AB (SE) 2005-08-18 WO disclosed